Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | PER2 | O15055 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7603912 | 0.99 | PIK3CD (0.41) | PIK3CDKMT2AMEN1PKML3MBTL1 | |
| SCHEMBL7607202 | 0.94 | PIK3CD (0.45) | PIK3CDKMT2AMEN1PKMLMNA | |
| SCHEMBL7603739 | 0.88 | KMT2A (0.39) | PIK3CDKMT2AMEN1PKML3MBTL1 | |
| SCHEMBL7603997 | 0.86 | KMT2A (0.40) | PIK3CDKMT2AMEN1PKML3MBTL1 | |
| SCHEMBL7606762 | 0.84 | CHRM2 (0.35) | PIK3CDL3MBTL1LMNA | |
| SCHEMBL827615 | 0.83 | PIK3CD (0.46) | PIK3CDKMT2AMEN1PKML3MBTL1 | |
| SCHEMBL7603320 | 0.82 | PIK3CD (0.44) | PIK3CDKMT2AMEN1PKMLMNA | |
| SCHEMBL7605055 | 0.82 | CHRM2 (0.36) | PIK3CDLMNA | |
| SCHEMBL7604247 | 0.82 | PRMT5 (0.33) | PER2ACHE | |
| SCHEMBL7604655 | 0.81 | PIK3CD (0.49) | PIK3CDKMT2AMEN1PKML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6497886-B1 | SOLVENTS FOR PHARMACEUTICAL PREPARATIONS WHICH, BESIDES EXCELLENT DISSOLVING CAPACITY FOR ACTIVE INGREDIENT USED, ALSO PROVIDE EXCELLENT MISCIBILITY WITH OTHER SOLVENTS AND GOOD PHYSIOLOGICAL TOLERABILITY | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-24 | — | — | US | claimed |
| EP-0934080-B1 | 1,3-BIS-(N-LACTAMYL) PROPANE AND THE PHARMACEUTICAL AND COSMETIC USE THEREOF | BASF AG (DE) | 2002-06-12 | — | — | EP | claimed |
| US-6497886-B1 | SOLVENTS FOR PHARMACEUTICAL PREPARATIONS WHICH, BESIDES EXCELLENT DISSOLVING CAPACITY FOR ACTIVE INGREDIENT USED, ALSO PROVIDE EXCELLENT MISCIBILITY WITH OTHER SOLVENTS AND GOOD PHYSIOLOGICAL TOLERABILITY | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-24 | — | — | US | disclosed |
| EP-0934080-B1 | 1,3-BIS-(N-LACTAMYL) PROPANE AND THE PHARMACEUTICAL AND COSMETIC USE THEREOF | BASF AG (DE) | 2002-06-12 | — | — | EP | disclosed |